Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. Uraki R, Ito M, Kiso M, Yamayoshi S, et al. Lancet Infect Dis 2023;23:402-403.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uraki R, Ito M, Kiso M, Yamayoshi S, et al. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate. Lancet Infect Dis 2023;23:402-403.
PMID: 36773622